Q3 2023 Holdings
Filed 2023-11-14 | 37 holdings | $949.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $180.9M | 8,493,321 | 19.0% |
| Rayzebio Inc | COM | 75525N107 | $89.2M | 4,016,847 | 9.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $47.3M | 3,082,622 | 5.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $45.7M | 4,684,167 | 4.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $45.6M | 14,444,444 | 4.8% |
| Merus N V | COM | N5749R100 | $40.7M | 1,726,214 | 4.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $40.4M | 2,954,902 | 4.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $38.2M | 3,000,000 | 4.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $32.6M | 1,563,513 | 3.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $30.0M | 1,973,253 | 3.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $28.1M | 2,916,667 | 3.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $27.6M | 2,744,125 | 2.9% |
| Hillevax Inc | COM | 43157M102 | $27.4M | 2,037,313 | 2.9% |
| Savara Inc(SVRA) | COM | 805111101 | $27.2M | 7,184,865 | 2.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $25.0M | 1,090,000 | 2.6% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $23.8M | 2,070,000 | 2.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $23.5M | 2,623,677 | 2.5% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $19.5M | 2,173,913 | 2.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $19.2M | 2,105,386 | 2.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $15.6M | 3,092,273 | 1.6% |
| Mersana Therapeutics Inc | COM | 59045L106 | $14.4M | 11,328,000 | 1.5% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $14.1M | 5,658,034 | 1.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $13.0M | 2,142,856 | 1.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $12.7M | 927,706 | 1.3% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $9.9M | 6,573,300 | 1.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $9.1M | 5,304,410 | 1.0% |
| Acelyrin Inc | COM | 00445A100 | $8.8M | 864,332 | 0.9% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $7.5M | 3,422,397 | 0.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $7.1M | 1,040,754 | 0.8% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $6.8M | 2,208,812 | 0.7% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $5.0M | 288,949 | 0.5% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $4.5M | 515,000 | 0.5% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $3.6M | 295,034 | 0.4% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $3.6M | 924,170 | 0.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $951.5K | 77,042 | 0.1% |
| Rallybio Corp | COM | 75120L100 | $905.0K | 268,532 | 0.1% |
| Affimed N V | COM | N01045108 | $682.7K | 1,428,571 | 0.1% |